About this trial
This is a prospective, observational study to investigate molecular mechanisms mediating the systemic inflammatory process, and changes to metabolism, and their impact on brain injury, survival, and functional outcomes after cardiac arrest. Investigators have shown that cardiac arrest induces changes in the numbers and properties of circulating immune cells, shifting the balance towards a pro-inflammatory phenotype and there is increased interest in the inflammatory pathways and the signaling mechanisms through which they are modulated. Participants will undergo blood sampling during 7 days following cardiac arrest, and analyses performed. Patient characteristics, clinical circumstances, and outcomes will be recorded and their associations with these inflammatory pathways characterized.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Aged 18 years or older
Admitted to the intensive care unit after cardiac arrest episode
Unresponsive after resuscitation
Disqualifiers
Moribund / actively dying at the time of evaluation
Informed consent cannot be obtained within 24 hours of resuscitation
Hemoglobin less than 7.0 g/dL, active high-volume bleeding, or requiring a transfusion
Trial population
Cardiac arrest survivors with encephalopathy admitted to the intensive care unit and unresponsive after resuscitation
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Correlations between inflammatory markers and clinical outcomes
Correlations between inflammatory markers and clinical outcomes
Correlations between inflammatory markers and biomarkers of neurological and cardiac injury
Correlations between inflammatory markers and biomarkers of neurological and cardiac injury
Secondary outcomes
Characterization of post-resuscitation inflammatory mechanisms and their regulators
Characterization of post-resuscitation inflammatory mechanisms and their regulators
Brown Fat activity
Correlations between 12,13 diHOME, blood glucose, and outcome
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
MaineHealth
Lead sponsor
National Institute of General Medical Sciences (NIGMS)
Collaborator
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator